BRPI0814893A2 - derivados de naftiridina como moduladores de canal de potássio. - Google Patents

derivados de naftiridina como moduladores de canal de potássio.

Info

Publication number: BRPI0814893A2
Authority: BR; Brazil
Prior art keywords: potassium channel; channel modulators; naphthyridine derivatives; compound; naphthyridine
Prior art date: 2007-08-01

Application number

BRPI0814893A

Other languages

English (en)

Inventor

Jean-Michel Vernier

Martha De La Rosa

Original Assignee

Valeant Pharmaceuticals Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-08-01

Filing date

2008-07-31

Publication date

2015-09-15

2008-07-31 Application filed by Valeant Pharmaceuticals Int filed Critical Valeant Pharmaceuticals Int

2015-09-15 Publication of BRPI0814893A2 publication Critical patent/BRPI0814893A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Liquid Crystal Substances (AREA)
Medicinal Preparation (AREA)
Adhesives Or Adhesive Processes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0814893A 2007-08-01 2008-07-31 derivados de naftiridina como moduladores de canal de potássio. BRPI0814893A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US96286207P	2007-08-01	2007-08-01
US12/181,126 US8563566B2 (en)	2007-08-01	2008-07-28	Naphthyridine derivatives as potassium channel modulators
PCT/US2008/071803 WO2009018466A1 (en)	2007-08-01	2008-07-31	Naphthyridine derivatives as potassium channel modulators

Publications (1)

Publication Number	Publication Date
BRPI0814893A2 true BRPI0814893A2 (pt)	2015-09-15

Family

ID=39865205

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0814893A BRPI0814893A2 (pt)	2007-08-01	2008-07-31	derivados de naftiridina como moduladores de canal de potássio.

Country Status (15)

Country	Link
US (1)	US8563566B2 (pt)
EP (2)	EP2311836A1 (pt)
JP (1)	JP2010535244A (pt)
KR (1)	KR20100068373A (pt)
CN (1)	CN101778848A (pt)
AT (1)	ATE495175T1 (pt)
AU (1)	AU2008282118A1 (pt)
BR (1)	BRPI0814893A2 (pt)
CA (1)	CA2695196A1 (pt)
DE (1)	DE602008004555D1 (pt)
MX (1)	MX2010001189A (pt)
PL (1)	PL2183250T3 (pt)
RU (1)	RU2481347C2 (pt)
TW (1)	TW200922571A (pt)
WO (1)	WO2009018466A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8722929B2 (en) *	2006-10-10	2014-05-13	Valeant Pharmaceuticals International	N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
US8367684B2 (en) *	2007-06-13	2013-02-05	Valeant Pharmaceuticals International	Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en)	2007-08-01	2013-10-22	Valeant Pharmaceuticals International	Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) *	2007-08-13	2010-08-31	Valeant Pharmaceuticals International	Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
TWI504395B (zh)	2009-03-10	2015-10-21		Substituted 3-amino-2-mercaptoquinoline as a KCNQ2 / 3 modifier
TW201038565A (en) *	2009-03-12	2010-11-01	Gruenenthal Gmbh	Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
TWI461197B (zh)	2009-03-12	2014-11-21		2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
TWI475020B (zh)	2009-03-12	2015-03-01		The substituted nicotine amide as a KCNQ2 / 3 modifier
WO2010122064A1 (en)	2009-04-21	2010-10-28	Neurosearch A/S	Substituted naphthyridine derivatives and their medical use
JP5837934B2 (ja)	2010-08-27	2015-12-24	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	Ｋｃｎｑ２／３調節因子としての置換２−オキソ−および２−チオキソ−ジヒドロキノリン−３−カルボキサミド
TW201211007A (en)	2010-08-27	2012-03-16	Gruenenthal Gmbh	Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
BR112013004562A2 (pt)	2010-08-27	2016-09-06	Gruenenthal Gmbh	2-óxi-quinolina-3-carboxamidas substituídas como moduladores kcnq2/3
EP2611780A1 (en)	2010-09-01	2013-07-10	Grünenthal GmbH	Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators
CN102241608A (zh) *	2011-05-12	2011-11-16	天津市汉康医药生物技术有限公司	瑞替加滨化合物及其组合物
US8846656B2 (en)	2011-07-22	2014-09-30	Novartis Ag	Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
CN108250128A (zh) *	2012-09-27	2018-07-06	江苏先声药业有限公司	作为钾通道调节剂的化合物
GB201305668D0 (en)	2013-03-28	2013-05-15	Glaxosmithkline Ip Dev Ltd	Avs6 Integrin Antagonists
US10065945B2 (en)	2014-01-24	2018-09-04	Merck Sharp & Dohme Corp.	Isoquinoline derivatives as MGAT2 inhibitors
GB201417094D0 (en)	2014-09-26	2014-11-12	Glaxosmithkline Ip Dev Ltd	Novel compounds
GB201417002D0 (en)	2014-09-26	2014-11-12	Glaxosmithkline Ip Dev Ltd	Novel compound
GB201604680D0 (en)	2016-03-21	2016-05-04	Glaxosmithkline Ip Dev Ltd	Chemical Compounds
CN109071441A (zh) *	2016-04-22	2018-12-21	小野药品工业株式会社	Kcnq2-5通道活化剂的晶体多晶型
CN110511220B (zh)	2018-05-22	2022-04-01	上海挚盟医药科技有限公司	作为钾通道调节剂的对二氨基苯衍生物、其制备方法及其在医药上的应用
CN116535353A (zh) *	2022-01-25	2023-08-04	上海挚盟医药科技有限公司	作为钾通道调节剂的酰胺类化合物及其制备和应用
TW202515557A (zh) *	2023-08-17	2025-04-16	加拿大商再諾製藥公司	雜芳基胺化合物及其用途

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4181803A (en) *	1973-12-14	1980-01-01	Eisai Co., Ltd.	Propiophenone derivatives and preparation thereof
DE3337593A1 (de)	1982-10-27	1984-05-03	Degussa Ag, 6000 Frankfurt	2-amino-3-acylamino-6-benzylamino-pyridin-derivate mit antiepileptischer wirkung
EP0110091B1 (de)	1982-10-27	1987-01-21	Degussa Aktiengesellschaft	2-Amino-3-Acylamino-6-benzylamino-pyridin-Derivate mit anti-epileptischer Wirkung
EP0189788B1 (de) *	1985-01-23	1989-09-13	ASTA Pharma Aktiengesellschaft	Synergistische Kombination von Flupirtin und nicht-steroidalen Antiphlogistika
DE3604575A1 (de)	1985-02-23	1986-08-28	Degussa Ag, 6000 Frankfurt	Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
EP0193056B1 (de) *	1985-02-23	1989-06-07	ASTA Pharma Aktiengesellschaft	Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
JP2583067B2 (ja) *	1987-08-04	1997-02-19	住友化学工業株式会社	モノアゾ化合物およびそれを用いて疎水性繊維材料を染色または捺染する方法
GB8800199D0 (en)	1988-01-06	1988-02-10	Beecham Group Plc	Pharmaceutical preparation
MC2029A1 (fr)	1988-05-16	1990-04-25	Asta Pharma Ag	(n-heterocyclyl)-3 diamino-2,6 pyridines substituees et leurs n-oxydes,preparation de ces composes et leur application comme medicaments
US5629307A (en) *	1989-10-20	1997-05-13	Olney; John W.	Use of ibogaine in reducing excitotoxic brain damage
US6004945A (en) *	1990-05-10	1999-12-21	Fukunaga; Atsuo F.	Use of adenosine compounds to relieve pain
IN172468B (pt) *	1990-07-14	1993-08-14	Asta Medica Ag
US5643921A (en)	1990-09-26	1997-07-01	E.R. Squibb & Sons, Inc.	Cardiopulmonary bypass and organ transplant using a potassium channel activator
US5234947A (en)	1991-11-07	1993-08-10	New York University	Potassium channel activating compounds and methods of use thereof
DE4200259A1 (de)	1992-01-08	1993-07-15	Asta Medica Ag	Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
US5262419A (en)	1992-06-11	1993-11-16	E. R. Squibb & Sons, Inc.	Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
CA2115792C (en) *	1993-03-05	2005-11-01	David J. Mayer	Method for the treatment of pain
US5428039A (en)	1994-02-20	1995-06-27	The Center For Innovative Technology	Method for electively achieving reversible hyperpolarized cardiac arrest
FI971334L (fi) *	1994-08-03	1997-04-01	Asta Medica Ag	Indoli-, indatsoli-, pyridopyrroli- ja pyridopyratsolijohdannaiset, joilla on antiastmaattinen, antiallerginen, anti-inflammatorinen ja immunomoduloiva vaikutus
DE69434794T2 (de) *	1994-09-22	2007-07-12	Smith, Richard Alan, La Jolla	Kombination von dextromethorphan mit quinidine oder quinine sulfat zur behandlung verschiedener refraktärer störungen
US5679706A (en)	1994-09-30	1997-10-21	Bristol-Myers Squibb Company	Combination of a potassium channel activator and an antiarrhythmic agent
CN1160115C (zh)	1994-12-12	2004-08-04	奥默罗斯公司	用于抑制疼痛,炎症和痉挛的冲洗液和方法
DE19539861A1 (de)	1995-10-26	1997-04-30	Asta Medica Ag	Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
DE19701694A1 (de)	1997-01-20	1998-07-23	Asta Medica Ag	Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung
PE68599A1 (es)	1997-04-25	1999-09-26	Smithkline Beecham Corp	Inhibidores de proteasas
US5760007A (en) *	1997-07-16	1998-06-02	Ortho Pharmaceutical Corporation	Anticonvulsant derivatives useful in treating neuropathic pain
AU8561298A (en)	1997-08-08	1999-03-01	Chugai Seiyaku Kabushiki Kaisha	Remedies for complications of diabetes
US6593335B1 (en)	1997-12-18	2003-07-15	Abbott Laboratories	Potassium channel openers
US6265417B1 (en)	1997-12-18	2001-07-24	Abbott Laboratories	Potassium channel openers
US6211171B1 (en) *	1998-05-19	2001-04-03	Dalhousie University	Use of antidepressants for local analgesia
JP3441970B2 (ja)	1998-06-30	2003-09-02	株式会社サミー	豆腐の製造方法及び製造装置
JP2000143510A (ja)	1998-11-16	2000-05-23	Taisho Pharmaceut Co Ltd	外用組成物
AU764921B2 (en)	1998-12-14	2003-09-04	Cellegy Pharmaceuticals, Inc.	Compositions and methods for the treatment of anorectal disorders
US6281211B1 (en) *	1999-02-04	2001-08-28	Euro-Celtique S.A.	Substituted semicarbazides and the use thereof
GB9903476D0 (en) *	1999-02-17	1999-04-07	Zeneca Ltd	Therapeutic agents
AU3216600A (en) *	1999-03-10	2000-09-28	Warner-Lambert Company	Analgesic compositions comprising anti-epileptic compounds and methods of using same
EP1163225A1 (en)	1999-03-17	2001-12-19	Signal Pharmaceuticals, Inc.	Compounds and methods for modulation of estrogen receptors
AT409083B (de) *	1999-04-01	2002-05-27	Sanochemia Pharmazeutika Ag	Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
US6610324B2 (en)	1999-04-07	2003-08-26	The Mclean Hospital Corporation	Flupirtine in the treatment of fibromyalgia and related conditions
GB9915414D0 (en)	1999-07-01	1999-09-01	Glaxo Group Ltd	Medical use
CZ20014488A3 (cs)	1999-07-06	2003-01-15	Eli Lilly And Company	Selektivní antagonisté iGluR5 receptoru pro léčení migrény
US6472165B1 (en)	1999-08-03	2002-10-29	Arzneimittelwerk Dresden Gmbh	Modulatory binding site in potassium channels for screening and finding new active ingredients
CA2378241A1 (en)	1999-08-04	2001-02-15	Icagen, Inc.	Benzanilides as potassium channel openers
NZ527771A (en)	1999-08-04	2005-04-29	Icagen Inc	Methods for treating or preventing anxiety
US6495550B2 (en)	1999-08-04	2002-12-17	Icagen, Inc.	Pyridine-substituted benzanilides as potassium ion channel openers
US6117900A (en)	1999-09-27	2000-09-12	Asta Medica Aktiengesellschaft	Use of retigabine for the treatment of neuropathic pain
US6383511B1 (en) *	1999-10-25	2002-05-07	Epicept Corporation	Local prevention or amelioration of pain from surgically closed wounds
KR100733187B1 (ko) *	1999-10-26	2007-06-27	이데미쓰 고산 가부시키가이샤	폴리프로필렌계 필름 및 다층 적층체
US6538004B2 (en)	2000-03-03	2003-03-25	Abbott Laboratories	Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
US20020015730A1 (en)	2000-03-09	2002-02-07	Torsten Hoffmann	Pharmaceutical formulations and method for making
TWI287984B (en)	2000-10-17	2007-10-11	Wyeth Corp	Pharmaceutical composition for modulating bladder function
US6589986B2 (en)	2000-12-20	2003-07-08	Wyeth	Methods of treating anxiety disorders
US6469042B1 (en)	2001-02-20	2002-10-22	Bristol-Myers Squibb Company	Fluoro oxindole derivatives as modulators if KCNQ potassium channels
WO2002080898A2 (en)	2001-04-04	2002-10-17	Wyeth	Methods for treating hyperactive gastric motility
GB0121214D0 (en)	2001-08-31	2001-10-24	Btg Int Ltd	Synthetic method
US6831087B2 (en) *	2001-11-09	2004-12-14	Hoffmann-La Roche Inc.	Pyridine substituted isoquinoline derivatives
WO2003068769A1 (en)	2002-02-12	2003-08-21	Pfizer Inc.	Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
US6984647B2 (en)	2002-05-17	2006-01-10	Janssen Pharmaceutica N.V.	Aminotetralin-derived urea modulators of vanilloid VR1 receptor
MXPA04011594A (es) *	2002-05-29	2005-03-07	Hoffmann La Roche	Derivados n-acilaminobenceno como inhibidores selectivos de monoamino oxidasa b.
WO2003106454A1 (en)	2002-06-12	2003-12-24	Orchid Chemicals & Pharmaceuticals Ltd	1h-isoquinoline-oxazolidinone derivaties and their use as antibacterial agents
AUPS312602A0 (en)	2002-06-21	2002-07-18	James Cook University	Organ arrest, protection, preservation and recovery
US7419981B2 (en) *	2002-08-15	2008-09-02	Pfizer Inc.	Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
IS7839A (is) *	2002-11-22	2004-05-23	Merck Frosst Canada Ltd.	4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar
US7045551B2 (en)	2002-11-22	2006-05-16	Bristol-Myers Squibb Company	1-aryl-2-hydroxyethyl amides as potassium channel openers
WO2004058704A2 (en)	2002-12-23	2004-07-15	Icagen, Inc.	Quinazolinones as potassium channel modulators
MXPA05006463A (es)	2002-12-27	2005-08-26	Lundbeck & Co As H	Derivados de 1,2,4-triaminobenceno, utiles para tratar transtornos del sistema nervioso central.
JP2006516573A (ja)	2003-01-31	2006-07-06	メルク　エンド　カムパニー　インコーポレーテッド	糖尿病の治療および予防のためのジペプチジルペプチダーゼ阻害薬としての３−アミノ−４−フェニルブタン酸誘導体
WO2004080950A1 (en)	2003-03-14	2004-09-23	H. Lundbeck A/S	Substituted aniline derivatives
AR043507A1 (es) *	2003-03-14	2005-08-03	Lundbeck & Co As H	Derivados de anilina sustituidos y composiciones farmaceuticas
MXPA05010000A (es)	2003-03-21	2005-11-17	Lundbeck & Co As H	Derivados de p-diaminobenceno substituidos.
US7276608B2 (en) *	2003-07-11	2007-10-02	Bristol-Myers Squibb Company	Tetrahydroquinoline derivatives as cannabinoid receptor modulators
EP1663239A4 (en)	2003-09-10	2008-07-23	Cedars Sinai Medical Center	KALIUM CHANNEL-MEDIATED FEEDING OF MEDICINES BY THE BLOOD BRAIN BARRIER
US20050089559A1 (en) *	2003-10-23	2005-04-28	Istvan Szelenyi	Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
DE10359335A1 (de)	2003-10-23	2005-05-25	Viatris Gmbh & Co. Kg	Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
CA2560346A1 (en) *	2004-04-13	2005-10-27	Icagen, Inc.	Polycyclic pyridines as potassium ion channel modulators
RU2006139930A (ru)	2004-05-03	2008-06-10	Дюк Юниверсити (Сша/Сша) (Us)	Составы для содействия снижению веса
UA89503C2 (uk) *	2004-09-13	2010-02-10	Х. Луннбек А/С	Заміщені похідні аніліну
WO2006054513A1 (ja)	2004-11-19	2006-05-26	Kissei Pharmaceutical Co., Ltd.	神経因性疼痛の予防又は治療剤
EP1688141A1 (en)	2005-01-31	2006-08-09	elbion AG	The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
US7683058B2 (en)	2005-09-09	2010-03-23	H. Lundbeck A/S	Substituted pyrimidine derivatives
JP2009256208A (ja)	2006-08-17	2009-11-05	Dainippon Sumitomo Pharma Co Ltd	フタリド誘導体またはその薬学的に許容される塩
NZ575652A (en) *	2006-08-23	2011-08-26	Valeant Pharmaceuticals Int	Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
US8367684B2 (en) *	2007-06-13	2013-02-05	Valeant Pharmaceuticals International	Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en)	2007-08-01	2013-10-22	Valeant Pharmaceuticals International	Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) *	2007-08-13	2010-08-31	Valeant Pharmaceuticals International	Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
CA2765678A1 (en) *	2009-06-22	2010-12-29	Christopher Blackburn	Substituted hydroxamic acids and uses thereof

2008
- 2008-07-28 US US12/181,126 patent/US8563566B2/en active Active
- 2008-07-31 CN CN200880101421A patent/CN101778848A/zh active Pending
- 2008-07-31 PL PL08796974T patent/PL2183250T3/pl unknown
- 2008-07-31 BR BRPI0814893A patent/BRPI0814893A2/pt not_active IP Right Cessation
- 2008-07-31 AU AU2008282118A patent/AU2008282118A1/en not_active Abandoned
- 2008-07-31 CA CA2695196A patent/CA2695196A1/en not_active Abandoned
- 2008-07-31 WO PCT/US2008/071803 patent/WO2009018466A1/en not_active Ceased
- 2008-07-31 RU RU2010107284/04A patent/RU2481347C2/ru not_active IP Right Cessation
- 2008-07-31 JP JP2010520200A patent/JP2010535244A/ja active Pending
- 2008-07-31 EP EP10014573A patent/EP2311836A1/en not_active Withdrawn
- 2008-07-31 DE DE602008004555T patent/DE602008004555D1/de active Active
- 2008-07-31 AT AT08796974T patent/ATE495175T1/de not_active IP Right Cessation
- 2008-07-31 EP EP08796974A patent/EP2183250B1/en not_active Not-in-force
- 2008-07-31 KR KR1020107004388A patent/KR20100068373A/ko not_active Withdrawn
- 2008-07-31 MX MX2010001189A patent/MX2010001189A/es not_active Application Discontinuation
- 2008-08-01 TW TW097129406A patent/TW200922571A/zh unknown

Also Published As

Publication number	Publication date
WO2009018466A1 (en)	2009-02-05
US20090170885A1 (en)	2009-07-02
KR20100068373A (ko)	2010-06-23
US8563566B2 (en)	2013-10-22
MX2010001189A (es)	2010-08-10
CN101778848A (zh)	2010-07-14
RU2481347C2 (ru)	2013-05-10
ATE495175T1 (de)	2011-01-15
EP2183250A1 (en)	2010-05-12
PL2183250T3 (pl)	2011-06-30
TW200922571A (en)	2009-06-01
EP2183250B1 (en)	2011-01-12
EP2311836A1 (en)	2011-04-20
RU2010107284A (ru)	2011-09-10
AU2008282118A1 (en)	2009-02-05
JP2010535244A (ja)	2010-11-18
CA2695196A1 (en)	2009-02-05
DE602008004555D1 (de)	2011-02-24

Publication	Publication Date	Title
BRPI0814893A2 (pt)	2015-09-15	derivados de naftiridina como moduladores de canal de potássio.
BRPI1012770B8 (pt)	2021-05-25	derivados de tiofeno
CO6491116A2 (es)	2012-07-31	Derivados de 5-fluoropirimidinona
UY32292A (es)	2010-06-30	Agonistas de s1p1 y métodos de preparación y uso
NI201200020A (es)	2012-05-22	Derivados de n1 - sulfonil - 5 - fluoropirimidinona
CR20130369A (es)	2013-09-20	Novedosos derivados heterocíclicos
MA37940A2 (fr)	2016-06-30	Nouveaux dérivés bicycliques
CR20120297A (es)	2012-10-25	Espironucleósidos uracílicos oxetánicos
CR20130118A (es)	2013-04-17	DERIVADOS DE PIRAZINA COMO BLOQUEADORES DE ENaC
EP2709985A4 (en)	2014-12-10	AMINE DERIVATIVES AS KALIUM CHANNEL BLOCKERS
ECSP11011244A (es)	2011-09-30	Nuevos herbicidas.
BRPI0821102A2 (pt)	2015-06-16	Preparação de derivados de di-hidropirrol como intermediários
CR20130625A (es)	2014-02-04	Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
UY32553A (es)	2010-11-30	Nuevos derivados de la pirrolidinadiona espiroheterocíclicos 3-sustituidos
ECSP12011651A (es)	2012-03-30	Derivados de 5-fluoro-2-oxopirimidina-1(2h)-carboxilato
ECSP12011652A (es)	2012-03-30	Derivados de 5-fluoro-2-oxopirimidinona-1 (2h)-carboxamida substituida-n1
ECSP12011653A (es)	2012-03-30	Derivados de n1-acil-5-fluoropirimidinona
UY34251A (es)	2013-04-05	derivados de isoxazolina como compuestos insecticidas.
CR20130431A (es)	2013-12-09	5-(fenil)/piridinil-etinil)-2-piridina/ 2-pirimidina-carboxamidas como moduladores de mglur5
CR20130041A (es)	2013-03-25	ISOXAZOLO[5,4-b]PIRIDINAS HERBICIDAS
CL2012000278A1 (es)	2012-10-12	Proceso para la obtencion de derivados de 5-trifluorometil-pirimidinas; y uno de los compuestos intermediarios considerados.
CR20140495A (es)	2014-12-01	5-amino[1,4]thiazines como inhibidores de bace1
CO6761304A2 (es)	2013-09-30	Nuevos compuestos de bezodioxol-piperazina
CR20110057A (es)	2013-01-25	Proceso para la preparacion de derivados de benzoimidazol-2-il pirimidina
EA201691331A1 (ru)	2017-01-30	Способ получения органических соединений

Legal Events

Date	Code	Title	Description
2015-12-08	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 6A E 7A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.